ConductScience.org, home
Study to Evaluate the Efficacy and Safety of K-877 in Adult Patients With Fasting High Triglyceride Levels and Mild or Moderate Renal Impairment
API referenceFor AI assistants

Trial · NCT03011450

Adverse events212

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

1 to 20 of 212

Download this page as JSON
TypeEventOrgan systemGroupAffectedAt riskEvents
otherGlomerular filtration rate decreasedInvestigationsK-877: 12-Week Efficacy0311
otherGlomerular filtration rate decreasedInvestigationsPlacebo:12-Week Efficacy0159
otherGlomerular filtration rate decreasedInvestigationsK-877: 40-Week Extension2292
otherGlomerular filtration rate decreasedInvestigationsFenofibrate 40-Week Extension8154
seriousNormochromic normocytic anaemiaBlood and lymphatic system disordersK-877: 12-Week Efficacy0311
seriousNormochromic normocytic anaemiaBlood and lymphatic system disordersPlacebo:12-Week Efficacy0159
seriousNormochromic normocytic anaemiaBlood and lymphatic system disordersK-877: 40-Week Extension0292
seriousNormochromic normocytic anaemiaBlood and lymphatic system disordersFenofibrate 40-Week Extension1154
seriousAcute myocardial infarctionCardiac disordersK-877: 12-Week Efficacy1311
seriousAcute myocardial infarctionCardiac disordersPlacebo:12-Week Efficacy0159
seriousAcute myocardial infarctionCardiac disordersK-877: 40-Week Extension2292
seriousAcute myocardial infarctionCardiac disordersFenofibrate 40-Week Extension0154
seriousAngina pectorisCardiac disordersK-877: 12-Week Efficacy0311
seriousAngina pectorisCardiac disordersPlacebo:12-Week Efficacy0159
seriousAngina pectorisCardiac disordersK-877: 40-Week Extension2292
seriousAngina pectorisCardiac disordersFenofibrate 40-Week Extension0154
seriousAtrial fibrillationCardiac disordersK-877: 12-Week Efficacy1311
seriousAtrial fibrillationCardiac disordersPlacebo:12-Week Efficacy0159
seriousAtrial fibrillationCardiac disordersK-877: 40-Week Extension1292
seriousAtrial fibrillationCardiac disordersFenofibrate 40-Week Extension0154

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Next page

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT03011450/events

API referenceFor AI assistants